Sihuan Pharmaceutical Holdings Group Ltd. (FRA:TEL1)
Germany flag Germany · Delayed Price · Currency is EUR
0.1450
0.00 (0.00%)
At close: Dec 4, 2025

Sihuan Pharmaceutical Holdings Group Company Description

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States.

It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.

The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions.

It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas.

In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business.

Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Sihuan Pharmaceutical Holdings Group Ltd.
Country Bermuda
Founded 2001
Industry Pharmaceutical Preparations
Employees 2,667
CEO Weicheng Guo

Contact Details

Address:
Office Tower, Convention Plaza
Wan Chai
Hong Kong
Phone 852 3628 3911
Website sihuanpharm.com

Stock Details

Ticker Symbol TEL1
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 2834

Key Executives

Name Position
Weicheng Guo Chief Executive Officer
Guili Miao Chief Financial Officer